Tidal Investments’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
8,209
-20,162
| -71% | -$3.06M | 0.01% | 901 |
|
|
2025
Q1 | $4.27M | Buy |
28,371
+19,175
| +209% | +$2.89M | 0.03% | 425 |
|
|
2024
Q4 | $1.7M | Buy |
9,196
+744
| +9% | +$137K | 0.01% | 745 |
|
|
2024
Q3 | $1.66M | Buy |
8,452
+2,319
| +38% | +$457K | 0.02% | 729 |
|
|
2024
Q2 | $1.27M | Buy |
6,133
+836
| +16% | +$173K | 0.02% | 760 |
|
|
2024
Q1 | $1.44M | Buy |
5,297
+2,646
| +100% | +$717K | 0.02% | 688 |
|
|
2023
Q4 | $627K | Buy |
2,651
+1,072
| +68% | +$253K | 0.01% | 831 |
|
|
2023
Q3 | $309K | Buy |
1,579
+174
| +12% | +$34.1K | 0.01% | 1051 |
|
|
2023
Q2 | $295K | Buy |
1,405
+90
| +7% | +$18.9K | 0.01% | 1054 |
|
|
2023
Q1 | $265K | Buy |
1,315
+61
| +5% | +$12.3K | 0.01% | 1065 |
|
|
2022
Q4 | $273K | Buy |
1,254
+113
| +10% | +$24.6K | 0.01% | 893 |
|
|
2022
Q3 | $225K | Buy |
1,141
+52
| +5% | +$10.3K | 0.01% | 919 |
|
|
2022
Q2 | $233K | Sell |
1,089
-70
| -6% | -$15K | 0.01% | 929 |
|
|
2022
Q1 | $329K | Buy |
1,159
+152
| +15% | +$43.1K | 0.01% | 797 |
|
|
2021
Q4 | $379K | Buy |
1,007
+188
| +23% | +$70.8K | 0.01% | 697 |
|
|
2021
Q3 | $338K | Buy |
819
+244
| +42% | +$101K | 0.01% | 632 |
|
|
2021
Q2 | $213K | Buy |
+575
| New | +$213K | 0.01% | 679 |
|